Condition

Liver Cirrhoses

ClinicalTrials.gov condition label

Clinical trials12
Recruiting3
Common interventions15
Lead sponsors shown11

Clinical trials

12 shown
A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver CirrhosisNCT07291141 · 2025-12-18
RECRUITING
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver DiseaseNCT07058155 · 2025-12-17
RECRUITING
Antibiotic Prophylaxis in Patients Undergoing GVONCT04140578 · 2017-01-28
RECRUITING
HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic PatientsNCT04254822 · 2020-06-01
UNKNOWN
EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients.NCT04191369 · 2019-11-01
UNKNOWN
Simplified Monitoring Myanmar SM2 StudyNCT04113629 · 2019-01-22
COMPLETED
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal VaricesNCT03624517 · 2018-09-19
TERMINATED
MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI)NCT03483272 · 2018-01-08
COMPLETED
The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric VaricesNCT03171805 · 2017-06-01
UNKNOWN
Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive AssessmentNCT03443934 · 2017-04-01
COMPLETED
Viatorr CX Case-control Study for Complications of Portal HypertensionNCT03083925 · 2016-05-23
COMPLETED
Role of SWE-change After TIPS in the Prediction of Prognosis After TIPSNCT03072615 · 2013-04-01
COMPLETED

Common interventions

Anti-Obesity Pharmacotherapy (Class Effect)DRUG1CarvedilolDRUG1Endoscopic ultrasoundDIAGNOSTIC_TEST1Endoscopic variceal ligationPROCEDURE1ErtapenemDRUG1EsophagogastroduodenoscopyDIAGNOSTIC_TEST1HCV point of care machineDEVICE1Lifestyle Counseling - Diet & Physical-Activity ProgramBEHAVIORAL1OctreotideDRUG1PropranololDRUG1Sleeve GastrectomyPROCEDURE1Stiffness measurementDIAGNOSTIC_TEST1TIPSDEVICE1Transjugular intrahepatic portosystemic shuntPROCEDURE1Transjugular Intrahepatic Portosystemic Shunt (TIPS)PROCEDURE1

Trial status mix

COMPLETED5
RECRUITING3
UNKNOWN3
TERMINATED1

Phase mix

NA4
PHASE43

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.